BIOMAT Database Logo BIOMAT Database Logo

[New studies in GM2 gangliosidoses]. 1975

C Klibansky, and A Blonder

UI MeSH Term Description Entries
D005733 Gangliosidoses A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway. Ganglioside Storage Diseases,Ganglioside Storage Disorders,Gangliosidosis,Ganglioside Storage Disease,Ganglioside Storage Disorder,Storage Disease, Ganglioside,Storage Diseases, Ganglioside,Storage Disorder, Ganglioside,Storage Disorders, Ganglioside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Klibansky, and A Blonder
Nomenclature of GM2-gangliosidoses.
May 1980, Clinical genetics,
C Klibansky, and A Blonder
Serial 1H-MRS in GM2 gangliosidoses.
March 2008, European journal of pediatrics,
C Klibansky, and A Blonder
Neurophysiological investigations in GM1 and GM2 gangliosidoses.
September 1984, Neuropediatrics,
C Klibansky, and A Blonder
Thymic alterations in GM2 gangliosidoses model mice.
August 2010, PloS one,
C Klibansky, and A Blonder
Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.
October 2014, Current protocols in human genetics,
C Klibansky, and A Blonder
Hexosaminidases and ganglioside catabolism in the GM2-gangliosidoses.
December 1974, Chemistry and physics of lipids,
C Klibansky, and A Blonder
Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
March 2007, Clinica chimica acta; international journal of clinical chemistry,
C Klibansky, and A Blonder
Glycosphingolipid degradation and animal models of GM2-gangliosidoses.
August 1998, Journal of inherited metabolic disease,
C Klibansky, and A Blonder
Clinical course of GM2 gangliosidoses. A correlative attempt.
September 1984, Neuropediatrics,
C Klibansky, and A Blonder
Biochemical consequences of mutations causing the GM2 gangliosidoses.
October 1999, Biochimica et biophysica acta,
Copied contents to your clipboard!